Economic Evaluation of Selective Neonatal Bacillus Calmette-Guérin Vaccination of High-risk Infants in Ireland
This study evaluates the cost-effectiveness of selective BCG vaccination compared with strategies of universal and no vaccination.
This Academic Publication is available from
Date of publication:
01 Lún 2018
Authors:
Conor Teljeur, Patrick S Moran, Patricia Harrington, Karina Butler, Brenda Corcoran, Joan O'Donnell, Cara Usher, Darina O'Flanagan, Kevin Connolly, Máirín Ryan.
Journal:
The Pediatric Infectious Disease Journal
Digital object identifier:
doi: 10.1097/INF.0000000000001891
Type of output:
Original Research
Suggested Citation:
Teljeur C, Moran PS, Harrington P, Butler K, Corcoran B, O'Donnell J, Usher C, O’Flanagan D, Connolly K & Ryan M. Economic Evaluation of Selective Neonatal Bacillus Calmette-Guérin Vaccination of High-risk Infants in Ireland. The Pediatric Infectious Disease Journal 2018;37(8):759-67.